Chris Sterzinger

Title: Chris Sterzinger: Innovator in Diagnostic Formulations

Introduction

Chris Sterzinger is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of diagnostic formulations, particularly in the development of innovative compounds for medical use. With a total of 3 patents to his name, Sterzinger's work is paving the way for advancements in the diagnosis of neurological conditions.

Latest Patents

One of Sterzinger's latest patents is a labeled iodinated tropane formulation. This diagnostic formulation comprises a tropane with a radioactive concentration of at least 1.6 mCi/mL, maintained for at least about 51 hours post-creation. The formulation optionally includes a radiolabeled dopamine transporter (DAT) ligand, which is useful in diagnosing Parkinson's disease. An example of such a ligand is [I]-2β-carbomethoxy-3β-(4-fluorophenyl)-N-(3-iodo-E-allyl)nortropane.

Career Highlights

Throughout his career, Chris Sterzinger has worked with various companies, including Alseres Pharmaceuticals, Inc. and Likeminds, Inc. His experience in these organizations has contributed to his expertise in the field of pharmaceuticals and diagnostics.

Collaborations

Sterzinger has collaborated with several professionals in his field, including Cara Ferreira and David Leyh. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in medical diagnostics.

Conclusion

Chris Sterzinger is a prominent inventor whose work in diagnostic formulations is making a significant impact in the medical field. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.